1. BLLN raised approximately $273.1 million in its IPO. 2. Shares began trading at $60, expected to close November 7, 2025. 3. The IPO reflects strong investor interest in genetic testing. 4. Multiple firms managed the IPO, indicating confidence in BLLN's market position. 5. Gunderson Dettmer provided support through major financing rounds, showcasing expertise.
The significant capital raised indicates strong market confidence. Historically, successful IPOs often lead to price appreciation.
The IPO's size and market entry are pivotal for BLLN's growth, affecting investor sentiment and future funding.
The immediate trading post-IPO could see volatility, but long-term effects depend on BLLN's performance.
REDWOOD CITY, Calif., Nov. 6, 2025 /PRNewswire/ -- Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, a leading law firm in technology and life sciences transactions, represented long-time client BillionToOne, Inc. (NASDAQ:BLLN), a molecular diagnostics company on a mission to make powerful and accessible genetic tests available to all, in its upsized initial public offering of 4.6 million shares of Class A common stock at a price to the public of $60 per share, generating approximately $273.1 million in aggregate gross proceeds. The shares began trading on the Nasdaq Global Select Market on November 6, 2025, and the offering is expected to close on November 7, 2025.
Gunderson Dettmer represented BillionToOne through multiple major financing rounds, from its Series A to late-stage equity and debt private rounds. Gunderson's strategic counsel supported BillionToOne from early-stage funding to public markets entry, navigating a dynamic and complex capital markets environment including the current government shutdown.
J.P. Morgan, Piper Sandler, Jefferies and William Blair are acting as joint book-running managers for the offering. Stifel, Wells Fargo Securities and BTIG are also acting as book-running managers for the offering.
The Gunderson deal team included corporate partner Nick Harley, Public Companies/Public Offerings partners Andrew Thorpe and Alexa Belonick, Public Companies/Public Offerings associates Elena Vespoli and Michael Tiab, corporate associates Jenny Whalen-Ball and Megan Wiener, executive compensation partner Michael Richman and associate Erik Ward, and senior paralegals Scott Paraker and Doug Ikegami.
About Gunderson Dettmer
Gunderson Dettmer is the preeminent international law firm with an exclusive focus on the innovation economy. The firm serves market-leading venture capital and growth equity investors and pioneering companies through inception, growth and maturity, as well as groundbreaking public companies that result from the global venture capital ecosystem. The firm's clear-cut focus and well-honed technical skill enables an accelerated pace and unmatched efficiency, delivering best-in-class value at each phase of a client's business.
View original content to download multimedia:https://www.prnewswire.com/news-releases/gunderson-dettmer-represents-long-time-client-billiontoone-in-its-upsized-273-1-million-initial-public-offering-302607889.html
SOURCE Gunderson Dettmer